SCHEMBL531168

SCHEMBL531168

O=C(O)CNP(=O)(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL28972551 0.97 LMNA (0.39)
Succinic Acid SCHEMBL28354180 0.92 EGLN1 (0.45)
Phosphoric Acid SCHEMBL30257820 0.90 MMP1 (0.35)
SCHEMBL6925210 0.74
Phosphoric Acid SCHEMBL27508881 0.73 LMNA (0.43)
SCHEMBL27457306 0.72 EGLN1 (0.40)
SCHEMBL22972312 0.72 TSHR (0.33)
SCHEMBL28817939 0.72 ENO1 (0.50)
SCHEMBL4320919 0.72 LMNA (0.40)
Hydrochloric Acid SCHEMBL10891934 0.70 ENO1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118184831-A Carbomer carrier structure polymer formed by carbomer and phosphoric acid amino acid, and preparation and application thereof 吉林省远志医学科技有限公司 2024-06-14 CN claimed
US-12391682-B2 Isoquinoline derivatives and their use for the treatment of parasitic infections ELANCO ANIMAL HEALTH GMBH (DE) 2025-08-19 US disclosed
EP-4003524-B1 ISOQUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PARASITIC INFECTIONS ELANCO ANIMAL HEALTH GMBH (DE) 2025-04-09 EP disclosed
CN-114423749-B Isoquinoline derivatives and their use for the treatment of parasitic infections 拜耳动物保健有限责任公司 2024-10-01 CN disclosed
CN-118184831-A Carbomer carrier structure polymer formed by carbomer and phosphoric acid amino acid, and preparation and application thereof 吉林省远志医学科技有限公司 2024-06-14 CN disclosed
US-20230220001-A1 METHOD FOR SYNTHESIS OF THIOETHER-CONTAINING PEPTIDES HEIDELBERG PHARMA RESEARCH GMBH (DE) 2023-07-13 US disclosed
CN-115835871-A Amorphous calcium carbonate for treating acidosis 阿莫菲克公司 2023-03-21 CN disclosed
US-20220274971-A1 ISOQUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PARASITIC INFECTIONS ELANCO ANIMAL HEALTH GMBH (DE) 2022-09-01 US disclosed
EP-4003524-A1 ISOQUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PARASITIC INFECTIONS Bayer Animal Health GmbH (DE) 2022-06-01 EP disclosed
CN-114423749-A Isoquinoline derivatives and their use for the treatment of parasitic infections 拜耳动物保健有限责任公司 2022-04-29 CN disclosed
CN-1242792-A Epoxy resin composition for fiber-reinforced composite material, prepreg, and fiber-reinforced composite material TORAY INDUSTRIES (JP) 2000-01-26 CN disclosed
US-5391564-A E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents SANKYO COMPANY, LIMITED (JP) 1995-02-21 US disclosed
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US disclosed
EP-0350315-B1 RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS SANKYO COMPANY LIMITED (JP) 1993-06-16 EP disclosed
EP-0315627-B1 A METHOD TO TREAT BLOOD RUBINSTEIN, Alan I. (US) 1992-08-19 EP disclosed
CN-1040728-A WATER-SOLUBLE OR WATER-DISPERSIBLE PESTICIDE GRANULES DU PONT (US) 1990-03-28 CN disclosed
EP-0350315-A1 Rhizoxin derivates and their use as anti-tumor agents SANKYO COMPANY LIMITED (JP) 1990-01-10 EP disclosed
EP-0315627-A4 A METHOD TO TREAT BLOOD. RUBINSTEIN ALAN I 1990-01-08 EP disclosed
EP-0315627-A1 A METHOD TO TREAT BLOOD. RUBINSTEIN ALAN I 1989-05-17 EP disclosed
WO-1988001507-A1 A METHOD TO TREAT BLOOD RUBINSTEIN ALAN I (US) 1988-03-10 WO disclosed